Numerical Simulation of Copper Deposition in the Hull Cell Based on Butler-Volmer Kinetics von Kovácsovics, I., Patzelt, T., Pilz, U., Herrmann, J., Bund, A.

Volltext

Reverse Numerical Simulation of Kinetic Parameters from Acidic Copper Hull Cell Deposition von Kovácsovics, I., Patzelt, T., Herrmann, J., Bund, A.

Volltext

Lineage-Specific Genome Architecture Links Enhancers and Non-coding Disease Variants to Target Gene Promoters von Javierre, Biola M., Burren, Oliver S., Wilder, Steven P., Kreuzhuber, Roman, Hill, Steven M., Sewitz, Sven, Cairns, Jonathan, Wingett, Steven W., Várnai, Csilla, Thiecke, Michiel J., Burden, Frances, Farrow, Samantha, Cutler, Antony J., Rehnström, Karola, Downes, Kate, Grassi, Luigi, Kostadima, Myrto, Freire-Pritchett, Paula, Wang, Fan, Martens, Joost H., Kim, Bowon, Sharifi, Nilofar, Janssen-Megens, Eva M., Yaspo, Marie-Laure, Linser, Matthias, Kovacsovics, Alexander, Clarke, Laura, Richardson, David, Datta, Avik, Flicek, Paul, Stunnenberg, Hendrik G., Todd, John A., Zerbino, Daniel R., Stegle, Oliver, Ouwehand, Willem H., Frontini, Mattia, Wallace, Chris, Spivakov, Mikhail, Fraser, Peter

Volltext

Fashion wave

Volltext bestellen

OCT and VEP correlate to disability in secondary progressive multiple sclerosis von Eklund, Anna, Huang-Link, Yumin, Kovácsovics, Beatrix, Dahle, Charlotte, Vrethem, Magnus, Lind, Jonas

Volltext

Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial von Burd, Amy, Levine, Ross L., Ruppert, Amy S., Mims, Alice S., Borate, Uma, Stein, Eytan M., Patel, Prapti, Baer, Maria R., Stock, Wendy, Deininger, Michael, Blum, William, Schiller, Gary, Olin, Rebecca, Litzow, Mark, Foran, James, Lin, Tara L., Ball, Brian, Boyiadzis, Michael, Traer, Elie, Odenike, Olatoyosi, Arellano, Martha, Walker, Alison, Duong, Vu. H., Kovacsovics, Tibor, Collins, Robert, Shoben, Abigail B., Heerema, Nyla A., Foster, Matthew C., Vergilio, Jo-Anne, Brennan, Tim, Vietz, Christine, Severson, Eric, Miller, Molly, Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley, Chen, Timothy, Stefanos, Mona, Druker, Brian, Byrd, John C.

Volltext

The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy von Moran, Amy E, Kovacsovics-Bankowski, Magdalena, Weinberg, Andrew D

Volltext

Science gone translational: the OX40 agonist story von Weinberg, Andrew D., Morris, Nicholas P., Kovacsovics-Bankowski, Magdalena, Urba, Walter J., Curti, Brendan D.

Volltext

Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML von Lancet, Jeffrey E., Cortes, Jorge E., Hogge, Donna E., Tallman, Martin S., Kovacsovics, Tibor J., Damon, Lloyd E., Komrokji, Rami, Solomon, Scott R., Kolitz, Jonathan E., Cooper, Maureen, Yeager, Andrew M., Louie, Arthur C., Feldman, Eric J.

Volltext

OX40 is a potent immune-stimulating target in late-stage cancer patients von Curti, Brendan D, Kovacsovics-Bankowski, Magdalena, Morris, Nicholas, Walker, Edwin, Chisholm, Lana, Floyd, Kevin, Walker, Joshua, Gonzalez, Iliana, Meeuwsen, Tanisha, Fox, Bernard A, Moudgil, Tarsem, Miller, William, Haley, Daniel, Coffey, Todd, Fisher, Brenda, Delanty-Miller, Laurie, Rymarchyk, Nicole, Kelly, Tracy, Crocenzi, Todd, Bernstein, Eric, Sanborn, Rachel, Urba, Walter J, Weinberg, Andrew D

Volltext

FGF2 from Marrow Microenvironment Promotes Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia von Traer, Elie, Martinez, Jacqueline, Javidi-Sharifi, Nathalie, Agarwal, Anupriya, Dunlap, Jennifer, English, Isabel, Kovacsovics, Tibor, Tyner, Jeffrey W, Wong, Melissa, Druker, Brian J

Volltext

AML with germline DDX41 variants is a clinicopathologically distinct entity with an indolent clinical course and favorable outcome von Li, Peng, White, Thomas, Xie, Wei, Cui, Wei, Peker, Deniz, Zeng, Gang, Wang, Huan-You, Vagher, Jennie, Brown, Sara, Williams, Margaret, Kovacsovics, Tibor, Patel, Jay L.

Volltext

Mid-term performance of His bundle pacing and usefulness of backup leads von Herbert, Julia, Kovacsovics, Arianne, Brito, Rita, Masson, Nicolas, Burri, Haran

Volltext

Functional integration of acute myeloid leukemia into the vascular niche von Cogle, C R, Goldman, D C, Madlambayan, G J, Leon, R P, Al Masri, A, Clark, H A, Asbaghi, S A, Tyner, J W, Dunlap, J, Fan, G, Kovacsovics, T, Liu, Q, Meacham, A, Hamlin, K L, Hromas, R A, Scott, E W, Fleming, W H

Volltext

A phase 1 trial of vadastuximab talirine combined with hypomethylating agents in patients with CD33-positive AML von Fathi, Amir T., Erba, Harry P., Lancet, Jeffrey E., Stein, Eytan M., Ravandi, Farhad, Faderl, Stefan, Walter, Roland B., Advani, Anjali S., DeAngelo, Daniel J., Kovacsovics, Tibor J., Jillella, Anand, Bixby, Dale, Levy, Moshe Y., O'Meara, Megan M., Ho, Phoenix A., Voellinger, Jenna, Stein, Anthony S.

Volltext

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma von Yousef, Sara, Kovacsovics-Bankowski, Magdalena, Salama, Mohamed E, Bhardwaj, Neelam, Steinbach, Mary, Langemo, Amanda, Kovacsovics, Tibor, Marvin, James, Binder, Mascha, Panse, Jens, Kröger, Nicolaus, Luetkens, Tim, Atanackovic, Djordje

Volltext

Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial von THOMAS, Xavier, BOIRON, Jean-Michel, STAMATOULLAS, Aspasia, VERNANT, Jean-Paul, TOURNILHAC, Olivier, BUZYN, Agnès, REMAN, Oumedaly, CHARRIN, Christiane, BOUCHEIX, Claude, GABERT, Jean, LHERITIER, Véronique, FIERE, Denis, HUGUET, Francoise, DOMBRET, Hervé, BRADSTOCK, Ken, VEY, Norbert, KOVACSOVICS, Tibor, DELANNOY, André, FEGUEUX, Nathalie, FENAUX, Pierre

Volltext

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial von FADERL, Stefan, WETZLER, Meir, MARIS, Michael, KOVACSOVICS, Tibor, GOLDBERG, Stuart, SEITER, Karen, HARI, Parameswaran, GREINER, Jochen, VEY, Norbert, RECHER, Christian, RAVANDI, Farhad, WANG, Eunice S, RIZZIERI, David, VASCONCELLES, Michael, HUEBNER, Dirk, KANTARJIAN, Hagop M, SCHILLER, Gary, JAGASIA, Madan, STUART, Robert, GANGULY, Siddhartha, AVIGAN, David, CRAIG, Michael, COLLINS, Robert

Volltext

Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA von Palladini, Giovanni, Kastritis, Efstathios, Maurer, Mathew S., Zonder, Jeffrey, Minnema, Monique C., Wechalekar, Ashutosh D., Jaccard, Arnaud, Lee, Hans C., Bumma, Naresh, Kaufman, Jonathan L., Medvedova, Eva, Kovacsovics, Tibor, Rosenzweig, Michael, Sanchorawala, Vaishali, Qin, Xiang, Vasey, Sandra Y., Weiss, Brendan M., Vermeulen, Jessica, Merlini, Giampaolo, Comenzo, Raymond L.

Volltext

Original OCT and VEP correlate to disability in secondary progressive multiple sclerosis von Eklund, Anna, Link, Yumin, Kovacsovics, Bea, Dahle, Charlotte, Vrethem, Magnus, Lind, Jonas

Volltext